Search

Search Constraints

You searched for: Author/Creator Broniscer, Alberto

Search Results

1. A pediatric brain tumor consortium phase II trial of capecitabine rapidly disintegrating tablets with concomitant radiation therapy in children with newly diagnosed diffuse intrinsic pontine gliomas. Issue 2 (1st November 2017)

2. A phase I/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium study. Issue 6 (3rd February 2020)

3. ATRT-03. MALIGNANT RHABDOID TUMORS ORIGINATING WITHIN AND OUTSIDE THE CENTRAL NERVOUS SYSTEM ARE CLINICALLY AND MOLECULARLY HETEROGENEOUS. Issue 2 (22nd June 2018)

4. Bithalamic gliomas may be molecularly distinct from their unilateral high‐grade counterparts. (12th March 2017)

5. Characteristics of patients ≥10 years of age with diffuse intrinsic pontine glioma: a report from the International DIPG/DMG Registry. Issue 1 (11th June 2021)

6. Concordance between the chang and the International Society of Pediatric Oncology (SIOP) ototoxicity grading scales in patients treated with cisplatin for medulloblastoma. Issue 4 (1st November 2013)

7. CRAN-21. PHASE II STUDY OF PEGINTERFERON ALFA-2b (PEGINTRON)/SYLATRON FOR PEDIATRIC PATIENTS WITH PROGRESSIVE OR RECURRENT CRANIOPHARYNGIOMA FOLLOWING RADIOTHERAPY: A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDY (PBTC-039). Issue 2 (22nd June 2018)

8. CRAN-21. PHASE II STUDY OF PEGINTERFERON ALFA-2b (PEGINTRON)/SYLATRON FOR PEDIATRIC PATIENTS WITH PROGRESSIVE OR RECURRENT CRANIOPHARYNGIOMA FOLLOWING RADIOTHERAPY: A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDY (PBTC-039). Issue 2 (22nd June 2018)

9. DIPG-11. ACTIVATION OF RAS SIGNALING AND DISTINCT MITOGEN-ACTIVATED PROTEIN KINASES (MAPKs) PROVIDES UNIQUE THERAPEUTIC VULNERABILITIES IN MUTANT HISTONE DIPG. (23rd April 2019)